EUVIMEDEUVIMED entdecken
Crossref

L26/P-723 Impact of ovarian stimulation protocols on embryo euploidy and clinical outcomes in PGT-A cycles: A focus on advanced material age(AMA)

S. Jeong, J.W. Kim, J. Ko, J. Ann, C.Y. Hur, J.H. Lim

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Jeong und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do GnRH antagonist, agonist (long/ultra-short), and mild stimulation protocols affect PGT-A euploidy rates and clinical pregnancy outcomes, particularly in advanced maternal age(AMA)? Summary answer After adjusting for age and AMH, GnRH ultra-short flare protocols significantly enhance embryo euploidy and clinical pregnancy outcomes over GnRH antagonist protocols, especially in AMA. What is known already While various ovarian stimulation protocols are routinely used in PGT-A cycles, their impact on chromosomal competence and subsequent clinical outcomes remains controversial. Although several studies have investigated whether controlled ovarian stimulation protocols influence euploidy rates, available evidence is limited and inconsistent. Comparative data addressing GnRH- antagonist(GnRH-anta), GnRH-agonist(GnRH-a), GnRH-ultra-short flare(GnRH-US), and mild stimulation(MS) protocols in the context of PGT-A outcomes are scarce, leaving uncertainty regarding the optimal strategy for maximizing both embryological and clinical success. Therefore, selecting an appropriate ovarian stimulation protocol is crucial, and this study aims to identify the optimal strategy for achieving pregnancy and maintaining successful pregnancy. Study design, size, duration This retrospective cohort study analyzed 1,824 PGT-A cycles at a single center (January 2021–October 2025). The platform transitioned from aCGH (n = 70) to NGS (n = 1,754). We compared four protocols: GnRH-anta (n = 964), GnRH-a (n = 353), GnRH-US (n = 194), and MS (n = 313). Multivariable logistic regression, adjusting for age and AMH, evaluated protocol impact on euploidy and clinical outcomes, with a predefined subgroup analysis for advanced maternal age(AMA, ≥40). Participants/materials, setting, methods Patients undergoing IVF with PGT-A were included. Ovarian stimulation was performed using GnRH-anta, GnRH-a, GnRH-US, or MS protocols. Multivariable logistic regression compared euploidy and pregnancy outcomes, adjusting for maternal age and AMH. A predefined subgroup analysis for women aged ≥40 years evaluated protocol effects independent of age-related fertility decline. All analyses aimed to identify the most effective protocol for maximizing success in advanced maternal age. Main results and the role of chance A total of 1,824 cycles and 4,112 embryos were analyzed. For the total population, the crude outcomes for GnRH-anta, GnRH-a, GnRH-US and MS protocols were: euploidy rates(23.2%, 20.5%, 18.6%, 14.5%), clinical pregnancy rates(CPR)(64.9%, 56.1%, 65.4%, 59.4%), and ongoing pregnancy rates/live birth rates(OPR/LBR)(54.8%, 42.8%, 46.2%, 49.3%), respectively. In AMA subgroup, crude outcomes were: euploidy rates(12.3%, 11.3%, 12.6%, 9.9%), CPR(53.8%, 48.3%, 62.5%, 55.6%) and OPR/LBR (47.6%, 31.7%, 43.8%, 50.0%). Adjusting for age and AMH, pairwise analyses showed that GnRH-US protocol was associated with significantly higher odds of obtaining euploid blastocysts compared to GnRH-anta (aOR 1.352, 95% CI 1.014-1.731, p = 0.039) and GnRH-a (aOR 1.500, 95% CI, 1.132-1.988, p = 0.009) protocols. Multivariable regression analysis, adjusting for age and AMH, revealed that GnRH-US consistently outperformed GnRH-anta in CPR for both the total population (aOR: 2.415, 95% CI: 1.382-4.221, p = 0.002) and the AMA subgroup (aOR: 2.584, 95% CI: 1.214-5.503, p = 0.014). Regarding OPR/LBR, GnRH-US showed significantly higher success rates than GnRH-anta in the total population (aOR: 2.21, 95% CI: 1.264-3.864, p = 0.005). Notably, in AMA patients, GnRH-US remained superior to both GnRH-anta (aOR: 2.351, 95% CI: 1.102-5.014, p = 0.027) and GnRH-a (aOR: 2.49, 95% CI: 1.152–5.380, p = 0.023). Limitations, reasons for caution The primary limitation is the retrospective design, introducing potential selection bias. Despite multivariable regression, unmeasured confounders like paternal factors may influence outcomes. Additionally, this single-center setting limits generalizability. Consequently, larger prospective, multicenter studies are essential to validate these clinical impacts and underlying mechanisms. Wider implications of the findings This study underscores that PGT-A success is fundamentally driven by the stimulation protocol’s efficiency in generating euploid embryos and their subsequent clinical competence. The ultra-short flare protocol offers a superior strategic advantage, particularly for patients of advanced maternal age, by maximizing both embryological and clinical potential in IVF cycles. Trial registration number No

Zitieren

APA

Jeong, S., Kim, J., Ko, J., Ann, J., Hur, C., & Lim, J. (2026). L26/P-723 Impact of ovarian stimulation protocols on embryo euploidy and clinical outcomes in PGT-A cycles: A focus on advanced material age(AMA). Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1050

Vancouver

Jeong S, Kim J, Ko J, Ann J, Hur C, Lim J. L26/P-723 Impact of ovarian stimulation protocols on embryo euploidy and clinical outcomes in PGT-A cycles: A focus on advanced material age(AMA). Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1050

BibTeX
@article{Jeong2026,
  author = {Jeong, S. and Kim, J.W. and Ko, J. and Ann, J. and Hur, C.Y. and Lim, J.H.},
  title = {L26/P-723 Impact of ovarian stimulation protocols on embryo euploidy and clinical outcomes in PGT-A cycles: A focus on advanced material age(AMA)},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1050}
}
Kostenlos starten →